【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 API Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases
3.1.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.1.1.4 Increasing preference for outsourcing APIs
3.1.2 Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.1.3 Stringent safety and handling regulations regarding APIs
3.2 Penetration & growth prospect mapping
3.3 Active Pharmaceutical Ingredient – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 API Market: Type of Synthesis Estimates & Trend Analysis
4.1 Active pharmaceutical ingredient market: Type of synthesis movement analysis
4.2 Biotech
4.2.1 Biotech market, 2014 – 2025 (USD Billion)
4.2.2 Monoclonal Antibodies
4.2.3 Monoclonal Antibodies market, 2014 – 2025 (USD Billion)
4.2.4 Recombinant proteins
4.2.5 Recombinant proteins market, 2014 – 2025 (USD Billion)
4.2.6 Vaccines
4.2.7 Vaccines market, 2014 – 2025 (USD Billion)
4.3 Synthetic
4.3.1 Synthetic market, 2014 – 2025 (USD Billion)
Chapter 5 API Market: Type of Manufacturer Estimates & Trend Analysis
5.1 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
5.2 Captive APIs
5.2.1 Captive APIs market, 2014 – 2025 (USD Billion)
5.3 Merchant APIs
5.3.1 Merchant APIs market, 2014 – 2025 (USD Billion)
Chapter 6 API Market: Type Estimates & Trend Analysis
6.1 Active pharmaceutical ingredient market: Type movement analysis
6.2 Generic APIs
6.2.1 Generic APIs market, 2014 – 2025 (USD Billion)
6.3 Innovative APIs
6.3.1 Innovative APIs market, 2014 – 2025 (USD Billion)
Chapter 7 API Market: Application Estimates & Trend Analysis
7.1 Active pharmaceutical ingredient market: Application movement analysis
7.2 Cardiovascular Disease
7.2.1 Cardiovascular Disease market, 2014 – 2025 (USD Billion)
7.3 Oncology
7.3.1 Oncology market, 2014 – 2025 (USD Billion)
7.4 CNS and Neurological Disorders
7.4.1 CNS and Neurological Disorders market, 2014 – 2025 (USD Billion)
7.5 Orthopedic Disorders
7.5.1 Orthopedic Disorders market, 2014 – 2025 (USD Billion)
7.6 Endocrinology
7.6.1 Endocrinology market, 2014 – 2025 (USD Billion)
7.7 Pulmonology
7.7.1 Pulmonology market, 2014 – 2025 (USD Billion)
7.8 Gastrointestinal Disorders
7.8.1 Gastrointestinal Disorders market, 2014 – 2025 (USD Billion)
7.9 Nephrology
7.9.1 Nephrology market, 2014 – 2025 (USD Billion)
7.10 Ophthalmology
7.10.1 Ophthalmology market, 2014 – 2025 (USD Billion)
7.10.2 Others market, 2014 – 2025 (USD Billion)
Chapter 8 API Market: Regional Estimates & Trend Analysis
8.1 Active pharmaceutical ingredient market share, by region, 2015 & 2025
8.2 North America
8.2.1 North America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.2.2 U.S
8.2.2.1 U.S active pharmaceutical Ingredient market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.2 UK
8.3.2.1 UK active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.3 Germany
8.3.3.1 Germany active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.4 India
8.4.4.1 India active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.3 Mexico
8.5.3.1 Mexico active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6 MEA
8.6.1 MEA active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 AbbVie, Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Boehringer Ingelheim GmbH
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Bristol-Myers Squibb Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Cipla, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Merck& Co., Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Albemarle Corporation
9.3.6.1 Company overview
9.3.6.2 Financial overview
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Aurobindo Pharma
9.3.7.1 Company overview
9.3.7.2 Financial overview
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Mylan N.V.
9.3.8.1 Company overview
9.3.8.2 Financial overview
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Teva Active Pharmaceuticals Industries Ltd.
9.3.9.1 Company overview
9.3.9.2 Financial overview
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Sun Pharmaceutical Industries, Ltd.
9.3.10.1 Company overview
9.3.10.2 Financial overview
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Dr. Reddy’s Laboratories Ltd
9.3.11.1 Company overview
9.3.11.2 Financial overview
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
【レポート販売概要】
■ タイトル：医薬品有効成分（API）の世界市場規模及び予測：合成別（バイオ技術、合成）、メーカー種類別（キャプティブ、マーチャント）、種類別（一般、革新的）、用途別、動向分析 2014-2025■ 英文：Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014-2025
■ 発行日：2017年1月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707013
■ 調査対象地域：グローバル
- Lexapro (大うつ病性障害)：医薬品市場予測及び分析（～2023）Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for …
- アメリカの自然食品/有機食品市場2015-2019The consumer demand for organic products has broadened. Natural and organic food stores and cooperatives are not the only vendors, but mainstream mass market stores and retailers like Tesco, Wal-Mart and Costco now provide organic products such as organic tea, cereals, oats and fats, seasonings like ketchup, spices powder and many others. Technavio's market research analysts predict the natural an …
- リウマチ性多発筋痛症治療のグローバル臨床試験動向（2014年H2）Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014" provides data on the Polymyalgia Rheumatica clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polymyalgia Rheumatica. It includes an overview of the trial numbers and …
- 抗体生産の世界市場：抗体生産装置（バイオリアクター、遠心機、限外ろ過装置）、抗体生産消耗品、モノクローナル抗体、ポリクローナル抗体Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies such as recombinant technology and antibody phage-display technology. Due t …
- 3Dマシンビジョンの世界市場展望2017-20276According to Stratistics MRC, the Global 3D Machine Vision Market is accounted for $1.26 billion in 2017 and is expected to reach $3.98 billion by 2026 growing at a CAGR of 13.5% during the forecast period. Integration of 3D vision frameworks with robot controllers, increasing interest for 3D object investigations in manufacturing applications, and high prerequisite of non-industrial 3D machine vi …
- ゲルマニウムの世界市場動向2014/2015The report presents a thorough study of germanium, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing germanium worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: germanium production in the country, major manu …
- バイオバンクの世界市場予測2016-2026Biobanks – How to Discover Trends, R&D and Sales Forecasts from 2016, Helping Your Influence Are you interested in the future of medical biobanking? If so, you can now gain technological and commercial predictions from 2016. That way you stay ahead for data, benefiting your authority. There explore trends in research and development, results, opportunities and revenue forecasts. That new study by …
- 食品/飲料包装用金属缶の世界市場2015-2019About metal cans Packaging in broad terms means the technology of enclosing a product for storage, distribution, sale, and use. Metal can packaging is one of the types of packaging. A metal can is a container for the storage and distribution of goods, and is composed of thin metal, usually steel or aluminum. These metal cans hold a wide range of products such as food, beverages, oils, and chemical …
- 世界の医療ワークフォース・マネジメント（WFM）システム市場予測（～2019）The global healthcare workforce management systems market is expected to grow at a double digit CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $1,453.8 million by 2019. The market is mainly driven by the growing need of healthcare professionals due to the increasing aging population and resultant increase in the prevalence of diseases in North America and Europe, tech …
- 日本の感染症検査市場2014This report provides an overview of the Japanese infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness EnvironmentMarket Structure Market Size, Growth, and Major Suppliers' Market SharesList of Tables …
- 屋内3Dレーザースキャナーの世界市場展望2017-20276According to Stratistics MRC, the Global Indoor 3D Laser Scanner market accounted for $3.79 billion in 2017 and is expected to reach $6.58 billion by 2026 growing at a CAGR of 6.3% during the forecast period. Increased accuracy reduces manual intervention and high precision are some of the key factors boosting the market growth. However, increasing price of these scanners, rising costs associated …
- ハイブリッドクラウドの世界市場2015-2019About hybrid cloud Hybrid cloud is a combination of on-premises, public, and private cloud computing, where applications can switch between private and public cloud depending on the workload. Enterprises are increasingly using the hybrid cloud model, as critical applications can be hosted more securely on private clouds compared to public cloud. Hybrid cloud computing helps enterprises achieve max …
- 世界の主要画像診断装置（医療機器）メーカー分析2014Complete report $14,500. Individual company assessments $2,450. The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. This unique study is designed to provide diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and im …
- 整形外科用医療機器の世界市場2016-2020About Orthopedic Devices Orthopedic devices are the instruments and implants used in orthopedic surgeries to replace an injured bone or missing joint and to support a damaged bone. These devices can be made of metal, ceramic, or plastic. Technavio’s analysts forecast the global orthopedic devices market to grow at a CAGR of 4.57% during the period 2016-2020. [Covered in this report] The report cov …
- 鉄鋳造品の世界市場2016-2020About Iron Castings Iron is the most commonly cast metal because of its relatively low cost, ease of casting, ease of machining, and desired physical properties. Therefore, iron foundries are highly integrated into the supply chain for a broad range of products, particularly for the automotive, machinery and equipment, and pipe and valve manufacturers. Technavio’s analysts forecast the global iron …
